2025-12-01 2026-03-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 15289555 bus:FullAccounts 2025-12-01 2026-03-31 15289555 bus:Micro-entities 2025-12-01 2026-03-31 15289555 bus:AuditExempt-NoAccountantsReport 2025-12-01 2026-03-31 15289555 bus:SmallCompaniesRegimeForAccounts 2025-12-01 2026-03-31 15289555 bus:PrivateLimitedCompanyLtd 2025-12-01 2026-03-31 15289555 2025-12-01 2026-03-31 15289555 2026-03-31 15289555 bus:RegisteredOffice 2025-12-01 2026-03-31 15289555 core:WithinOneYear 2026-03-31 15289555 core:AfterOneYear 2026-03-31 15289555 2024-12-01 15289555 bus:Director1 2025-12-01 2026-03-31 15289555 bus:Director1 2026-03-31 15289555 bus:Director1 2024-12-01 2025-11-30 15289555 bus:CompanySecretary1 2025-12-01 2026-03-31 15289555 bus:LeadAgentIfApplicable 2025-12-01 2026-03-31 15289555 2024-12-01 2025-11-30 15289555 2025-11-30 15289555 core:WithinOneYear 2025-11-30 15289555 core:AfterOneYear 2025-11-30 15289555 bus:EntityAccountantsOrAuditors 2024-12-01 2025-11-30 15289555 core:ComputerEquipment 2025-12-01 2026-03-31 15289555 core:ComputerEquipment 2026-03-31 15289555 core:ComputerEquipment 2025-11-30 15289555 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-03-31 15289555 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 15289555 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 15289555 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 15289555 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 15289555 core:Non-currentFinancialInstruments 2026-03-31 15289555 core:Non-currentFinancialInstruments 2025-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15289555
England and Wales
Unaudited Financial Statements
for the period ended 31 March 2026
for
RP BIOLOGICS LTD

RP BIOLOGICS LTD ###### Statement of Financial Position As at 31 March 2026
|  | £ | 2026 £ |  | £ | 2025 £
--- | --- | --- | --- | --- | --- | ---
Fixed assets |  |  | 437 |  |  | 872
Current assets |  | 14,371 |  |  | 9,465 |
Creditors: amount falling due within one year |  | (10,535) |  |  | (10,079) |
Net current assets/(liabilities) |  |  | 3,836 |  |  | (614)
Total assets less current liabilities |  |  | 4,273 |  |  | 258
Net assets/(liabilities) |  |  | 4,273 |  |  | 258
Capital and reserves |  |  | 4,273 |  |  | 258
For the period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. Signed on behalf of the board of directors:
--------------------------------------------- Renata Pankiewicz Director |  |
Date approved: 05 May 2026 1

RP BIOLOGICS LTD ###### Notes to the Accounts For the period ended 31 Mar 2026
Statutory Information Rp Biologics Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 15289555, registered office 36 Kirby Road, Waterbeach, Cambridge, CB25 9LX, England. The presentation currency is £ sterling.
1. | Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2. | Average number of employees Average number of employees during the period was 1 (2025: 1).
3. | Director Advances Credits Note At 31 March 2026 the director owed £637.41 to RP BIOLOGICS LTD. The loan is interest- free, unsecured and has no set repayment terms.
2